Company Filing History:
Years Active: 2025
Title: Michael Hadd: Innovator in Feline Diabetes Management
Introduction
Michael Hadd is an accomplished inventor based in San Jose, California. He has made significant contributions to the field of veterinary medicine, particularly in managing feline diabetes. His innovative approach has the potential to improve the quality of life for many cats suffering from this condition.
Latest Patents
Michael Hadd holds a patent for a compound aimed at managing feline diabetes. The patent details methods that include administering a total daily dosage of about 5 to 50 mg of Compound 1, which is designed to help felines in need. Additionally, the patent outlines the use of an SGLT inhibitor, where the effective amount administered is no more than 10 to 30% of the dose that would typically cause gastrointestinal issues in healthy felines.
Career Highlights
Michael is currently associated with Increvet, Inc., where he continues to develop innovative solutions for veterinary health. His work is characterized by a commitment to improving animal welfare through scientific advancements.
Collaborations
Michael collaborates with notable colleagues, including Albert Collinson and Brian Seed, who contribute to his research and development efforts.
Conclusion
Michael Hadd's contributions to the management of feline diabetes exemplify the impact of innovation in veterinary medicine. His work not only addresses a critical health issue but also enhances the lives of countless felines and their owners.